About
Kanghua Biological is a research and development, production, and operation of preventive biological products. The company's research and development, production base, SPF laboratory animal center, and high-tech bacterial and virus vaccine GMP production workshop occupy 30,000 square meters. Its existing product includes ACYW135 group Meningococcal Polysaccharide Vaccine, (trade name: Maicred) and Freeze-dried Rabies Vaccine for Human Use (Human Diploid Cells), (trade name: HDCV). It has been awarded the titles of "Postdoctoral Innovation Practice Base", "Sichuan Province Constructive Innovation Enterprise Cultivation Enterprise", "Sichuan Province Excellent Integrity Demonstration Unit" by the Personnel Department and the Science and Technology Department. It was founded in 2004 in Chengdu, Sichuan, China.
Position in the VCSift Database
- • 4,609 investors in VCSift focus on the biotech sector.
- • 76 investors are based in Chengdu, Sichuan, China.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Sectors
- biotech
- Location
- Chengdu, China
Contact Information
Find more investors like Chengdu
Search Investors